Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults

Vaccine
P S KulkarniS R Godse

Abstract

Hepatitis B virus (HBV) infection is highly prevalent world over, especially in developing countries. A new recombinant hepatitis B virus (GeneVac-B; Serum Institute of India Ltd.) vaccine is developed using Hansenula polymorpha yeast. We decided to assess the immunogenicity, and reactogenicity of this vaccine in a large adult population. Seven hundred eighty-eight adults subjects (age: 19-57 years, male:female ratio 35:1) received three 20 microg doses of a H. polymorpha-derived recombinant hepatitis B vaccine in months 0, 1, and 6. All the eligible subjects had negative baseline serum HBs Ag, and anti-HBs. The anti-HBs titer was obtained 1 month after the last dose of vaccine and was considered seroconverted if more than 1 mIU/ml, and seroprotective if more than 10 mIU/ml. The seroprotection rate was 96% and seroconversion rate was 97%. Seroconversion and seroprotection rates declined with increasing age. The minimum geometric mean titre of anti HBs was 443 mIU/ml (95% CI 407-482). Seroprotection was 96% in age group<40 years, while the same was 91% in >40 years group (Odd's ratio-2.9100, Z value-2.6183, highly significant). No other factor like smoking, tobacco-chewing, alcohol consumption, chronic diseases, and obesity, aff...Continue Reading

References

Jul 1, 1986·The Journal of Infection·B A ZajacE M Scolnick
Jun 1, 1996·Journal of the American Geriatrics Society·R G BennettM L Clements
Aug 7, 1998·Tissue Antigens·I DesombereG Leroux-Roels
Apr 18, 2002·Japanese Journal of Clinical Oncology·Chien-Jen ChenYa-Wen Yang
May 15, 2002·Journal of Pediatric Endocrinology & Metabolism : JPEM·Ilknur ArslanoğluMelda Karavuş
Jun 25, 2002·Annals of the Rheumatic Diseases·O ElkayamD Caspi
Jan 1, 1992·Biotechnology Advances·G GellissenC P Hollenberg
Jun 9, 2006·Clinical and Vaccine Immunology : CVI· ShivanandaP S Kulkarni
Nov 7, 2007·The Pediatric Infectious Disease Journal·Vijayakumar VeluSadras Panchatcharam Thyagarajan

❮ Previous
Next ❯

Citations

May 2, 2009·Archives of Pharmacal Research·Kyungdong BaeByungki Hur
Nov 7, 2007·The Pediatric Infectious Disease Journal·Vijayakumar VeluSadras Panchatcharam Thyagarajan
Dec 25, 2015·Fungal Genetics and Biology : FG & B·James M Wagner, Hal S Alper
Oct 22, 2011·Alcoholism, Clinical and Experimental Research·Elizabeth PorrettaCarol M Mason
Jun 22, 2016·Scientific Reports·Shigui YangLanjuan Li
Jun 9, 2006·Clinical and Vaccine Immunology : CVI· ShivanandaP S Kulkarni
Dec 15, 2020·FEMS Microbiology Reviews·Justyna Ruchala, Andriy A Sibirny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

© 2021 Meta ULC. All rights reserved